Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT03373851
Eligibility Criteria:
Inclusion Criteria:
* Adults
* 16 \<BMI \<40
* ASA I and II
* Patient with traumatic functional surgery - Knee and hip arthroplasty, shoulder surgery, tibial osteotomy / femoral osteotomy; or plastic and aesthetic surgery with volume correction of more than 30% of body surface area (bodylift), DIEP, DLA.
* Patient who should theoretically benefit of a postop self-controlled analgesia of morphine for 72 hours on average
* Patient informed of the modalities of the study with delivery of an information leaflet
* Free and informed consent collection
Exclusion Criteria:
* Patient refusing to participate in the study
* Language barrier
* Hypersensitivity to sufentanil,
* Respiratory failure
* Renal insufficiency (GFR \<30 ml / min)
* Epilepsy not controlled by treatment
* Psychic and mental illness not controlled by treatment
* Hepatocellular insufficiency (TP \<50%)
* Heart failure (LVEF \<50%)
* patients with chronic pain, treated with level 3 analgesic and / or already treated for neuropathic pain
* Drug-addicted patients
* Pregnant or lactating women
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03373851
Study Brief:
Protocol Section:
NCT03373851